Early Stage Venture Investing

Midwest Value Orientation

Exceptional Capital Returns

The VCapital Advantage

World-class due diligence and our team’s selection aptitude combine to bring exceptional venture capital opportunities online to accredited investors. Reasonable fees and low minimums make it easy to diversify your portfolio with exciting (and potentially world-changing) institutional-quality deals.

Midwest focus

Based in Chicago, we know what drives business success in the heartland and beyond.

High-quality deals

We seek opportunities to make a difference to the world and to your bottom line.

Early Stage

Early stage investors, we concentrate on the underserved $500k-$5M range.

Involved

Deep operating experience enables us to guide our funded entrepreneurs to successful outcomes.

Experienced

Our industry connections, expansive network, and 30-year track record gives us access to unique deals.

Selective

We only invest in opportunities that pass our rigorous screening and vetting process.

Invest with VCapital

Select and invest in the best opportunities for your portfolio using our online platform.
$25,000 minimum.

We offer two options for the management fee.

  • a one-time fee equal to 8% of the undersigned’s capital contribution to the Company.
  • an annual fee equal to 2% per annum of the undersigned’s capital contribution to the Company.

Current Opportunities

https://www.camrasvision.com | Medical Device | Research Park Triangle, NC

Camras Vision is developing the next generation of glaucoma treatments with their revolutionary device – The Camras Shunt. This patented device exceeds the ability of current prescription drug therapies and surgical treatments in treating glaucoma.
Learn more

https://getsynap.com | Software as a Service – CRM | Chicago, IL

Synap makes and sells software primarily for account management and customer success teams. Its flagship product is designed specifically for post-sales engagement, helping teams to build, collaborate, and execute on their plans to grow customer relationships.
Learn more

Recent Investments

http://simmachines.com | Software as a Service – Machine Learning | Chicago, IL

simMachines is changing the Machine Learning (ML) paradigm with its proprietary similarity-based technology, which is the only ML technology capable of providing transparency to the factors driving the prediction (what is called Predictions with The WHY™) at the speed and scale required for enterprise use.
Learn more

http://www.intensitytherapeutics.com | Pharmaceuticals, Biotechnology | Westport, CT

Our team invested $2.3 million in Intensity Therapeutics and raised an additional $1.5 million for the Company. Intensity Therapeutics is pioneering a new field of cancer treatment – in situ vaccination – to eliminate metastatic disease and prevent cancer from recurring.
Learn more

http://www.cleversafe.com | data storage | Chicago, IL

Cleversafe is the marketplace leader in dispersed storage technology for unstructured data in the petabyte-plus range. Our team raised $4.5 million through BVC. The company was purchased by IBM in Oct. 2015 for $1.3 billion.
Learn more

Opportunities Currently in Due Diligence

Real Estate Services Anonymous

RedFin for commercial real estate. This firm is disrupting the tenant rep space and has a management team with several previous successful exits.

Medical Devices Camras Vision

The former COO of the first company to receive FDA clearance for laser refractive surgery (PRK / LASIK) is leading a team that has developed a shunt for treatment of glaucoma, a leading cause of blindness.

New Media/Video Padcaster

The all-in-one tool for all tablets and cell phones which turns them into your own personal recording and video device.  This company already has significant revenue and is sold world-wide.

Biotech RMS Technologies

World renowned physician, Dr. Jon Odorico, MD, FACS from the University of Wisconsin, is developing a way to use a patient's own stem cells to fight Diabetes.

Biotech NuvOx

Through the use of their patented oxygen therapeutic, NuvOx received its IND for phase II in GBM, is currently in Phase I in stroke, and is about to begin Phase I in Sickle Cell.  There are even more applications on which their therapeutic may be used, and most of their studies have been funded from non-dilutive grants.

Quantum Computing Anonymous

Stealth company working on a unique and promising approach to quantum computing.

Become a Founding Investor

For a limited time, you may also join VCapital as a founding investor. You will have priority access to our dealflow, the opportunity to connect with portfolio company management teams, and participate in the proceeds in all successful deals, now and in the future!

Invest and Join Now

Get Started

Register now to see full deal information, get dealflow updates, or make an investment.